What is Predictive Oncology Inc Annual Revenue?

Predictive Oncology Inc Annual Revenue fell 0.24%, in the last year to $1.62 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is Predictive Oncology Inc Annual Net Profit?

Predictive Oncology Inc Annual Net Profit rose 9.44% in the last year to $12.66 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

What is Predictive Oncology Inc Price to Earning Ratio?

Predictive Oncology Inc Price to Earning Ratio is -0.63, which is negative.

What is Predictive Oncology Inc Stock Price?

Predictive Oncology Inc Stock Price fell 23.93% and underperformed its sector by 31.64% in the past year.

What is Predictive Oncology Inc Quarterly Revenue?

Predictive Oncology Inc Quarterly Revenue rose 91.36% YoY to $0.61 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

What is Predictive Oncology Inc Quarterly Net profit?

Predictive Oncology Inc Quarterly Net profit rose 37.57% YoY to $2.17 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

What is Predictive Oncology Inc Mutual Fund Holding?

Predictive Oncology Inc Mutual Fund Holding increased by 0.03% in the last quarter to 3.82.

What is Predictive Oncology Inc Promoter Share Holding?

Predictive Oncology Inc Promoter Share Holding stayed the same in the most recent quarter at 8.8%.

What is Predictive Oncology Inc Institutional Holding?

Predictive Oncology Inc Institutional Holding remained the same in the last quarter at 3.7%.

How is the Predictive Oncology Inc today?

The Predictive Oncology Inc today is trading in the green, up by 2.30% at 0.89.

How has Predictive Oncology Inc performed historically?

The Predictive Oncology Inc is currently trading up 2.30% on an intraday basis in the past week the index fell -7.29%. The index has been down -29.92% in the past quarter and fell -23.93% in the past year. You can view this in the overview section.

Predictive Oncology Inc XNAS: POAI

Predictive Oncology Inc Live Share Price Today, Share Analysis and Chart

Name: Predictive Oncology Inc: Is Infosys Ltd. worth buying?
Item: Predictive Oncology Inc
Rating: 1.23041675
Author: Trendlyne DVM scores

Download real time

0.89 0.02 (2.30%)

70.92% Fall from 52W High

34,558 XNAS Volume

XNAS 22 Apr, 2025 5:30 PM (EDT)

Predictive Oncology Inc Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	7.9
PE TTM Negative PE TTM Unavailable in chosen country	-0.6
PEG TTM Negative PEG TTM Unavailable in chosen country	-0.1
Price to Book Negative Price to Book Unavailable in chosen country	-39
Institutional holding current Qtr % Low in industry Unavailable in chosen country	3.7
Revenue Growth Qtr YoY % High in industry Unavailable in chosen country	91.4
Operating Revenue growth TTM % Negative Operating Revenue growth TTM % Unavailable in chosen country	-4.1
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	37.6
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	9.4
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-716.6
Piotroski Score Low in industry Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	-21.2

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

4.7 / 100

Technically Neutral

44.6 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Predictive Oncology Inc Stock Price Analysis

Day Price Range 2.3% 1 Day return Unavailable in chosen country	0.9 (LTP) 0.80.9 LowHigh
Week Price Range -7.3% 1 Week return Unavailable in chosen country	0.9 (LTP) 0.81 LowHigh
Month Price Range -19.8% 1 Month return Unavailable in chosen country	0.9 (LTP) 0.82.6 LowHigh
52 Week Price Range -23.9% 1 Year return Unavailable in chosen country	0.9 (LTP) 0.63.1 LowHigh

View full Share Price History

Predictive Oncology Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Predictive Oncology Inc's Revenue was higher than average estimate 1 time in past 1 year

EPS forecast

QUARTER
ANNUAL

Current EPS

-2.3

Avg. Estimate

-0.1

Low Estimate

-0.1

High Estimate

-0.1

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 94.0% in FY25

Consensus Recommendation

1 ANALYST Recommendations

HOLD

The consensus recommendation from 1 analyst for Predictive Oncology Inc is HOLD

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Predictive Oncology Inc Stock Analysis

Predictive Oncology Inc stock analysis with key metrics, changes, and trends.

Predictive Oncology Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$1.62 M	0.24%	negative	Annual Revenue fell 0.24%, in the last year to $1.62 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$12.66 M	9.44%	positive	Annual Net Profit rose 9.44% in the last year to $12.66 M. Its sector's average net profit growth for the last fiscal year was 4.36%.
Price to Earning Ratio	-0.63	-	negative	Price to Earning Ratio is -0.63, which is negative.
Stock Price	$0.89	-23.93%	negative	Stock Price fell 23.93% and underperformed its sector by 31.64% in the past year.
Quarterly Revenue	$0.61 M	91.36%	positive	Quarterly Revenue rose 91.36% YoY to $0.61 M. Its sector's average revenue growth YoY for the quarter was 8.5%.
Quarterly Net profit	$2.17 M	37.57%	positive	Quarterly Net profit rose 37.57% YoY to $2.17 M. Its sector's average net profit growth YoY for the quarter was 32.9%.
Mutual Fund Holding	3.82 %	0.03%	positive	Mutual Fund Holding increased by 0.03% in the last quarter to 3.82.
Promoter Share Holding	8.80 %	0%	neutral	Promoter Share Holding stayed the same in the most recent quarter at 8.8%.
Institutional Holding	3.70 %	0%	neutral	Institutional Holding remained the same in the last quarter at 3.7%.

VIEW LESS

Loading data..

Predictive Oncology Inc - Company Profile

What does Predictive Oncology Inc do?

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

55.98 K

2024

Gross Remuneration

Year

Predictive Oncology Inc Live Share Price Today, Share Analysis and Chart

70.92% Fall from 52W High

Predictive Oncology Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Predictive Oncology Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Predictive Oncology Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Predictive Oncology Inc's Revenue was higher than average estimate 1 time in past 1 year

EPS forecast

EPS is expected to grow by 94.0% in FY25

Consensus Recommendation

The consensus recommendation from 1 analyst for Predictive Oncology Inc is HOLD

Predictive Oncology Inc Stock Analysis

Predictive Oncology Inc stock analysis with key metrics, changes, and trends.

Annual Revenue fell 0.24%, in the last year to $1.62 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit rose 9.44% in the last year to $12.66 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio is -0.63, which is negative.

Stock Price fell 23.93% and underperformed its sector by 31.64% in the past year.

Quarterly Revenue rose 91.36% YoY to $0.61 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit rose 37.57% YoY to $2.17 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

Mutual Fund Holding increased by 0.03% in the last quarter to 3.82.

Promoter Share Holding stayed the same in the most recent quarter at 8.8%.

Institutional Holding remained the same in the last quarter at 3.7%.

Predictive Oncology Inc - Company Profile

What does Predictive Oncology Inc do?

Predictive Oncology Inc Management structure

Mr. Raymond F. Vennare

Chairman of the Board and Chief Executive Officer

Mr. Josh Blacher

Interim Chief Financial Officer and Principal Accounting Officer

Dr. Pamela Bush, PhD

Chief Business Officer

Predictive Oncology Inc Board of directors

Mr. Chuck Nuzum

Lead Independent Director

Dr. Veena Rao, PhD

Independent Director

Dr. Nancy Chung-Welch

Independent Director

Dr. Matthew J. Hawryluk, PhD

Independent Director

Mr. Gregory S. St.Clair, Sr

Independent Director

Dr. Daniel E. Handley, M.S.,PhD

Independent Director

Predictive Oncology Inc FAQ

How is Predictive Oncology Inc today?

Predictive Oncology Inc today is trading in the green, and is up by 2.30% at 0.89.

How has Predictive Oncology Inc performed historically?

Predictive Oncology Inc is currently trading up 2.30% on an intraday basis. In the past week the stock fell -7.29%. stock has been down -29.92% in the past quarter and fell -23.93% in the past year. You can view this in the overview section.